bencyclane has been researched along with Diabetes Mellitus, Type 2 in 1 studies
Bencyclane: A vasodilator agent found to be effective in a variety of peripheral circulation disorders. It has various other potentially useful pharmacological effects. Its mechanism may involve block of calcium channels.
Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kamchatnov, PR | 1 |
| Karalkin, AV | 1 |
| Chugunov, AV | 1 |
| Kabanov, AA | 1 |
| Bassé, DA | 1 |
| Mikhaĭlova, NA | 1 |
| Umarova, KhIa | 1 |
| Boĭko, AN | 1 |
1 trial available for bencyclane and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
[Patogenetic therapy of patients with diabetes mellitus type 2 and cerebral vascular insufficiency].
Topics: Bencyclane; Calcium Channel Blockers; Cerebrovascular Circulation; Cerebrovascular Disorders; Data I | 2008 |